TU Stock Analysis: Telus | NYSE
Telecom Services | NYSE, USA | Market Cap: 15.199m USD | 12M Return: -38.1% | CA87971M1032 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 52.1M
EPS Trend: -54.9%
Qual. Beats: -1
Rev. Trend: 81.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
TELUS Corporation is a Canadian telecommunications company headquartered in Vancouver, operating through three main segments: TELUS Technology Solutions, TELUS Health, and TELUS Digital Experience. Its core offerings include mobile and fixed voice and data services, internet protocol and television, cloud hosting, managed IT services, and home and business security solutions. Beyond traditional connectivity, TELUS has diversified into healthcare products and benefits administration through its health segment, and into AI-driven customer experience and digital trust services through its digital experience segment. The company was incorporated in 1998 and was renamed from TELUS Communications Inc. in February 2005.
The integrated telecommunications sector is characterized by high infrastructure barriers and concentrated competition, with Telus operating alongside other major Canadian carriers in both wireless and wireline markets. Teluss expansion into adjacent verticals like health-tech and digital customer experience reflects a broader industry trend where incumbents extend beyond connectivity into higher-margin software, data, and service offerings. The company trades on both the NYSE (TU) and the Toronto Stock Exchange, providing exposure to a domestically dominant carrier with growing international digital services operations.
- TELUS Health and Digital Experience segments accelerate revenue growth
- CRTC regulation caps wireless pricing and ARPU expansion
- Heavy 5G and fiber capex pressures free cash flow distribution
| Net Income: -919.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.04 > 1.0 |
| NWC/Revenue: -17.69% < 20% (prev -7.66%; Δ -10.02% < -1%) |
| CFO/TA 0.08 > 3% & CFO 4.59b > Net Income -919.0m |
| Net Debt (30.1b) to EBITDA (7.38b): 4.07 < 3 |
| Current Ratio: 0.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.57b) vs 12m ago 2.88% < -2% |
| Gross Margin: 38.87% > 18% (prev 34.89%; Δ 3.98% > 0.5%) |
| Asset Turnover: 34.41% > 50% (prev 33.68%; Δ 0.73% > 0%) |
| Interest Coverage Ratio: 1.75 > 6 (EBIT TTM 3.30b / Interest Expense TTM 1.88b) |
| A: -0.06 (Total Current Assets 7.11b - Total Current Liabilities 10.7b) / Total Assets 56.8b |
| B: -0.05 (Retained Earnings -2.91b / Total Assets 56.8b) |
| C: 0.06 (EBIT TTM 3.30b / Avg Total Assets 58.7b) |
| D: 0.31 (Book Value of Equity 13.3b / Total Liabilities 42.7b) |
| Altman-Z'' = 0.12 = B |
| DSRI: 1.01 (Receivables 4.18b/4.18b, Revenue 20.2b/20.4b) |
| GMI: 0.90 (GM 34.89% / 38.87%) |
| AQI: 1.01 (AQ_t 0.56 / AQ_t-1 0.56) |
| SGI: 0.99 (Revenue 20.2b / 20.4b) |
| TATA: -0.10 (NI -919.0m - CFO 4.59b) / TA 56.8b) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of September 15, 2026, the stock is trading at USD 9.10 with a total of 4,275,453 shares traded. Over the past week, the price has changed by -5.21%, over one month by -4.22%, over three months by -22.35% and over the past year by -38.10%.
Current recommended Stop Loss: 8.70 (which is 4.4% or 1.7 ATR below the current price).
Telus has received a consensus analysts rating of 3.56. Therefore, it is recommended to hold TU.
- StrongBuy: 3
- Buy: 5
- Hold: 9
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 10.3 | 13.5% |
Market Cap CAD = 21.1b (15.2b USD * 1.3869 USD.CAD)
P/E Forward = 17.6056
P/S = 0.7522
P/B = 1.5878
P/EG = 1.0988
Revenue TTM = 20.2b CAD
EBIT TTM = 3.30b CAD
EBITDA TTM = 7.38b CAD
Long Term Debt = 26.4b CAD (from longTermDebt, last quarter)
Short Term Debt = 5.03b CAD (from shortTermDebt, last quarter)
Debt = 31.5b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.1b CAD (calculated: Debt 31.5b - CCE 1.39b)
Enterprise Value = 51.1b CAD (21.1b + Debt 31.5b - CCE 1.39b)
Interest Coverage Ratio = 1.75 (Ebit TTM 3.30b / Interest Expense TTM 1.88b)
EV/FCF = 27.11x (Enterprise Value 51.1b / FCF TTM 1.89b)
FCF Yield = 3.69% (FCF TTM 1.89b / Enterprise Value 51.1b)
FCF Margin = 9.34% (FCF TTM 1.89b / Revenue TTM 20.2b)
Net Margin = -4.55% (Net Income TTM -919.0m / Revenue TTM 20.2b)
Gross Margin = 38.87% ((Revenue TTM 20.2b - Cost of Revenue TTM 12.4b) / Revenue TTM)
Gross Margin QoQ = 14.92% (prev 16.52%)
Tobins Q-Ratio = 0.90 (Enterprise Value 51.1b / Total Assets 56.8b)
Interest Expense / Debt = 5.98% (Interest Expense 1.88b / Debt 31.5b)
Taxrate = 35.36% (425.0m / 1.20b)
NOPAT = 2.13b (EBIT 3.30b * (1 - 35.36%))
Current Ratio = 0.67 (Total Current Assets 7.11b / Total Current Liabilities 10.7b)
Debt / Equity = 2.37 (Debt 31.5b / totalStockholderEquity, last quarter 13.3b)
Debt / EBITDA = 4.07 (Net Debt 30.1b / EBITDA 7.38b)
Debt / FCF = 15.94 (Net Debt 30.1b / FCF TTM 1.89b)
Total Stockholder Equity = 14.0b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.57% (Net Income -919.0m / Total Assets 56.8b)
RoE = -6.56% (Net Income TTM -919.0m / Total Stockholder Equity 14.0b)
RoCE = 8.16% (EBIT 3.30b / Capital Employed (Equity 14.0b + L.T.Debt 26.4b))
RoIC = 4.25% (NOPAT 2.13b / Invested Capital 50.1b)
WACC = 4.54% (E(21.1b)/V(52.5b) * Re(5.55%) + D(31.5b)/V(52.5b) * Rd(5.98%) * (1-Tc(0.35)))
Discount Rate = 5.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.85 | Cagr: 2.84%
[DCF] Terminal Value 77.97% ; FCFF base≈1.68b ; Y1≈1.93b ; Y5≈2.84b
[DCF] Fair Price = 8.06 (EV 42.8b - Net Debt 30.1b = Equity 12.7b / Shares 1.57b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -54.86 | EPS CAGR: -3.62% | SUE: -1.77 | # QB: -1
Revenue Correlation: 81.26 | Revenue CAGR: 0.94% | SUE: -0.17 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.13 | Chg30d=-30.17% | Revisions=-75% | Analysts=12
EPS current Year (2026-12-31): EPS=0.51 | Chg30d=-0.82% | Revisions=-84% | GrowthEPS=-25.2% | GrowthRev=-1.9%
EPS next Year (2027-12-31): EPS=0.54 | Chg30d=-3.18% | Revisions=-83% | GrowthEPS=+7.5% | GrowthRev=+0.5%
[Analyst] Revisions Ratio: -93% (up=0, down=40)